OpenAI’s Specialized Rosalind Model Poised to Revolutionize Pharma’s 15-Year Drug Pipeline
OpenAI’s GPT-Rosalind could slash pharma’s brutal 15-year drug pipeline using protein reasoning and genomics. But can AI truly replace wet-lab science?
Beyond Human Limits: How AI Is Slashing Drug Development From 15 Years to 18 Months
AI slashes drug development from 15 years to 18 months, challenging medical dogma. Faster treatments and lower costs are revolutionizing healthcare. What does this mean for untreatable diseases?